AGP Executive Report
Last update: 11 hours agoCannabis-Related Harms: A Monash study found cannabis-related hospital admissions in Victoria rose 49% from 2013 to 2023. Psychotic disorders accounted for 40% of cases, while admissions among women and girls climbed 75%. Cannabinoid Treatment Research: Neurotech International has dosed the first child in a pivotal trial of its cannabinoid therapy for autism. Researchers at the University of Regina are also studying CBD as a concussion treatment, and the FDA has cleared a pathway for conditional approval of a cannabinoid drug for canine bone-cancer pain. CBD Access: The TSA updated its policy to allow travelers to bring some CBD products on flights, while New Jersey signed reforms aimed at expanding access to its medicinal cannabis program.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.